Ironwood Pharma share price logo

Ironwood Pharma

NASDAQ: IRWD

Small Cap

$4.36

+0.13

(+3.07%)

as on

Ironwood Pharma Stock Performance

as on September 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $4.17
    $4.38
    downward going graph

    4.36%

    Downside

    0.46%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.26
    $5.78
    downward going graph

    71.10%

    Downside

    32.57%

    Upside

    downward going graph

Ironwood Pharma share price movements today

Previous Close
$4.23
Open
$4.23
Volume
2.0M
Market Cap
$689.1M
Day's Low - High
$4.17 - $4.38
52 Week Low - High
$1.26 - $5.78

Ironwood Pharma Historical Returns

1 Month Return
-2.98 %
3 Month Return
+ 19.49 %
1 Year Return
+ 200 %
3 Year Return
-54.32 %
5 Year Return
-65.75 %

Ironwood Pharma Stock Fundamentals & Key Indicators

Check Ironwood Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$689.1M

EPS (TTM)

0.796

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

5.31

Industry PE ratio

2.29

PEG Ratio

0.0020090719285847467

EBITDA

241.4M

Revenue (TTM)

389.3M

Profit Margin

99.76%

Return On Equity TTM

-57.40%

Ironwood Pharma Stock Valuation

Track how Ironwood Pharma P/E has moved over time to understand its valuation trends.

Ironwood Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-1.77x)

December 31, 2023

Industry (2.29x)

December 31, 2025

Today (22.47x)

December 31, 2025

Highest (805.45x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 22.47x

Ironwood Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ironwood Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$689.1M-65.75%5.3199.76%0.00%
BUY$21.3B148.54%16.5586.14%0.00%
HOLD$19.1B26.23%-47.5834.83%2.82%
BUY$40.0BNA18.7765.57%1.35%
BUY$30.3B-63.21%12.0170.87%2.86%

Stock Returns calculator for Ironwood Pharma Stock including INR - Dollar returns

The Ironwood Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ironwood Pharma investment value today

Current value as on today

₹3,35,753

Returns

₹2,35,753

(+235.75%)

Returns from Ironwood Pharma Stock

₹2,09,220 (+209.22%)

Dollar Impact

₹26,533 (+26.53%)

Analyst Recommendation on Ironwood Pharma Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Ironwood Pharma. Average target price of $6.1

Ironwood Pharma Share Price Target

Get share price movements and forecasts by analysts on Ironwood Pharma.

What analysts predicted

28.52%UPSIDE

Target Price

$6.1

Current Price

$4.36

Analyzed by

1 Analysts

Target

$6.10

Ironwood Pharma target price $6.1, a slight upside of 28.52% compared to current price of $4.36. According to 1 analysts rating.

Indian Investors' Interest in Ironwood Pharma Stock

Search interest for Ironwood Pharma Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-34% versus previous 30 day period

Ironwood Pharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
74
94
91
90
41
85
122
47
106
113
Gross Profit
49
94
61
90
13
84
121
47
106
113
Operating Income
11
24
25
31
-29
45
77
6
72
79
EBITDA
11
26
27
33
-10
46
76
8
74
80
Interest Expense
7
7
9
8
8
8
8
7
9
7
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
4
18
17
23
-36
37
68
0
65
73
Income Tax Expense
9
19
13
21
1
14
27
2
24
22
Net Income
-4
0
3
2
-37
23
40
-2
40
51
Net Profit Margin
65.52%
100.00%
67.43%
100.00%
33.33%
99.45%
99.61%
100.00%
99.58%
100.00%

Ironwood Pharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
298
346
428
389
413
410
442
351
296
Gross Profit
278
313
293
386
343
409
436
343
296
Operating Income
-77
-238
120
142
232
250
-945
93
118
EBITDA
-33
-144
128
141
233
261
197
97
104
Interest Expense
36
37
36
29
31
7
21
33
32
Depreciation
14
11
5
3
1
1
1
2
1
Income Before Tax
-116
-282
58
108
200
252
-948
65
70
Income Tax Expense
34
-5
-
2
-327
77
83
64
46
Net Income
-116
-282
21
106
528
175
-1,002
0
24
Net Profit Margin
93.49%
90.55%
68.40%
99.19%
82.98%
99.65%
98.61%
97.85%
100.00%

Ironwood Pharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-4
0
3
2
-37
23
40
61
40
51
Operating Cash Flow
44
33
9
15
19
-15
47
74
5
58
Investing Cash Flow
0
0
0
-
0
0
0
0
-
-
Financing Cash Flow
-15
-49
-27
-14
0
0
-
0
-
-199
Change in Cash
29
-16
-17
0
19
-15
47
75
5
-141

Ironwood Pharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-116
-282
21
106
528
175
-1,002
0
24
Operating Cash Flow
-99
-70
10
168
261
273
183
103
127
Investing Cash Flow
151
88
-11
-1
0
0
-1,026
0
0
Financing Cash Flow
19
30
-1
18
-4
-237
277
-106
0
Change in Cash
71
48
-1
185
257
36
-565
-3
126

Mutual Funds that own Ironwood Pharma Stock

Check out the Mutual Funds with significant holdings in Ironwood Pharma.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.598964%
5946927
VANGUARD HORIZON FUNDS
1.454158%
2402850
Fidelity Salem Street Trust
1.287216%
2126995
Federated Hermes MDT Series
1.219311%
2014790
VANGUARD EXPLORER FUND
0.987704%
1632083

Global Institutional Holdings in Ironwood Pharma

Funds
Holdings
Vanguard
5.56%
iShares
5.19%
SPDR
3.85%
Xtrackers
2.5%
Schwab
1.46%

Ironwood Pharma News & Key Events

  • img

    Today's Timeline - 26 November

    Wed, 05:48 PM

    -

    Ironwood shares rise 1.3% after Medicare sets LINZESS price at $136 for 30-day supply, effective January 1, 2027.

Insights on Ironwood Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 47.70M → 113.04M (in $), with an average increase of 30.5% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -2.27M → 51.29M (in $), with an average increase of 63.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, IRWD stock has moved up by 6.9%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IRWD has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 71.6% return, outperforming this stock by 124.1%

About Ironwood Pharma

Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the CONSTELLA brand throughout Canada and the European Union. Beyond its marketed offerings, Ironwood's development pipeline includes IW-3300, another GC-C agonist targeting various visceral pain conditions, such as interstitial cystitis/bladder pain syndrome and endometriosis. Additionally, the company is advancing CNP-104, an immune nanoparticle being investigated for biliary cholangitis. Ironwood maintains key strategic alliances with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. to support the ongoing development and market introduction of linaclotide. Established in 1998, the Boston, Massachusetts-based firm initially operated as Microbia, Inc. before officially rebranding to Ironwood Pharmaceuticals, Inc. in April 2008.
OrganisationIronwood Pharma
Headquarters100 Summer Street, Boston, MA, 02110, US
IndustryDrug Manufacturers - Specialty & Generic
CEOThomas A. McCourt
E-voting on sharesClick here to vote

Key Management of Ironwood Pharma

Name

Title

Mr. Thomas A. McCourt

CEO & Director

Ms. Tammi Gaskins

Senior Vice President & Chief Commercial Officer.

Mr. Ronald Silver

Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer

Dr. Rosario Lobrutto M.B.A., M.S., Ph.D.

VP & Global Head of Technical Operations

Mr. Chris Stamm

Vice President of Investor Relations & Communications

Mr. John Minardo

Senior VP, Chief Legal Officer & Secretary

Mr. Jeff Ruberti

Chief Strategy Officer

Dr. Jeffrey Silber M.D.

Chief Medical Officer, Head of Research & Drug Development

FAQs

What is Ironwood Pharma share price today?

Ironwood Pharma share price today is $4.36 as on at the close of the market. Ironwood Pharma share today touched a day high of $4.38 and a low of $4.17.

What is the 52 week high and 52 week low for Ironwood Pharma share?

Ironwood Pharma share touched a 52 week high of $5.78 on and a 52 week low of $1.26 on . Ironwood Pharma stock price today i.e. is closed at $4.36,which is 24.57% down from its 52 week high and 246.03% up from its 52 week low.

What is Ironwood Pharma's market capitalisation today?

Ironwood Pharma market capitalisation is $0.00T as on .

How to invest in Ironwood Pharma Stock (IRWD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ironwood Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ironwood Pharma Shares that will get you 0.3440 shares as per Ironwood Pharma share price of $4.36 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Ironwood Pharma Stock (IRWD) from India?

Indian investors can start investing in Ironwood Pharma (IRWD) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Ironwood Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Ironwood Pharma share’s latest price of $4.36 as on September 19, 2026 at 8:45 am IST, you will get 2.2936 shares of Ironwood Pharma. Learn more about fractional shares .

What are the returns that Ironwood Pharma has given to Indian investors in the last 5 years?

Ironwood Pharma stock has given -65.75% share price returns and 30.25% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?